Neuroimmune modulation a ‘new chapter’ for patients with RA intolerant to TNF inhibitors
CHICAGO — Neuroimmune modulation could be an “emerging therapeutic approach” for patients with rheumatoid arthritis who had incomplete response or […]
CHICAGO — Neuroimmune modulation could be an “emerging therapeutic approach” for patients with rheumatoid arthritis who had incomplete response or […]
JAK inhibitor treatment is not associated with stunted growth in children with common inflammatory diseases, according to a research letter
As physicians across specialties encounter increasing patient interest in GLP-1 receptor agonists, it is important for them to learn about
The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized
Enhanced premium tax credits, which have made Affordable Care Act coverage more accessible, will likely expire at the end of
A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for
Ambient listening documentation may soon become integral to clinical practice as AI advances reshape care delivery.Ambient scribes are poised to
Several changes in the 2026 Medicare Physicians Fee Schedule, or PFS, will help to better support primary, preventive and comprehensive
About one in eight adults say they are taking a GLP-1 receptor agonist as a treatment for obesity, diabetes or
I am here to tell you something that we do not discuss outside the walls of Healio and the parent
CHICAGO — Vagus nerve-mediated neuroimmune modulation by electrical stimulation using an implantable device was well-tolerated and had durable efficacy through
CHICAGO — Citrullinated protein-targeted chimeric antigen receptor regulatory T cells showed a promising safety profile in highly refractory patients with
SAN DIEGO — Forty-three percent of medical residents report using generative AI-based tools daily, but many expressed concerns about overreliance
Bruton’s tyrosine kinase inhibitors such as ibrutinib have significantly improved outcomes for chronic lymphocytic leukemia, but they can cause long-term
SAN DIEGO — Visual intelligence and collaborative AI approaches may advance health care, according to a keynote speaker at AIMed25.“Our
CHICAGO — Clinicians are increasingly concerned that AI will replace them, but experts said that this focus should shift towards
Many patients benefit from accessing their digital clinical notes, but significant disparities exist among groups that look at them.Black and
The winter holidays are imminently approaching. Gathering times like these are associated with rituals around food, beverages and gifts —
The design of hospital patient portals may prevent millions of people with limited English proficiency from fully participating in their
DALLAS — Results presented here showed patella resurfacing during total knee arthroplasty may not improve outcomes in patients with inflammatory
Treatment with once-daily brepocitinib improved skin disease, muscle and physical function measures for adults with dermatomyositis while minimizing steroid burden,
This month, our Healio Exclusive entitled “Recent approvals, CAR T-cell advances signal ‘exciting time’ in lupus nephritis,” highlights the literal
CHICAGO — In this Healio video interview, Micaela F. Bayard, MD, discussed women’s health and reproductive health outcomes in rheumatic
CHICAGO — Several presentations from ACR Convergence 2025 focused on how rheumatologists can use digital tools to engage underrepresented populations,
CHICAGO — In this video interview with Healio, Micaela F. Bayard, MD, discussed the use of GLP-1 receptor agonists in
Clinicians who used an ambient AI scribe for 30 days reported a “remarkable” reduction in burnout, according to results of
On a busy night in the ED, the difference between a controlled resuscitation and a crisis often depends on the